View in EDS

172P A multi-center, randomized, double-blind, parallel, two-group phase III clinical study on the efficacy and safety of QL1101 or bevacizumab in combination with paclitaxel and carboplatin in the first-line treatment of non-squamous non-small cell lung cancer

Saved in:
Bibliographic Details
Title: 172P A multi-center, randomized, double-blind, parallel, two-group phase III clinical study on the efficacy and safety of QL1101 or bevacizumab in combination with paclitaxel and carboplatin in the first-line treatment of non-squamous non-small cell lung cancer
Authors: Han, B1 (AUTHOR), Li, K2 (AUTHOR), Chu, T1 (AUTHOR), Bi, M3 (AUTHOR), Zhang, H4 (AUTHOR), Yu, Y5 (AUTHOR), Shi, J6 (AUTHOR), Zhang, X7 (AUTHOR), Chen, Z8 (AUTHOR), Han, C9 (AUTHOR), Bai, T9 (AUTHOR)
Source: Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 136076544
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 172P A multi-center, randomized, double-blind, parallel, two-group phase III clinical study on the efficacy and safety of QL1101 or bevacizumab in combination with paclitaxel and carboplatin in the first-line treatment of non-squamous non-small cell lung cancer
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Han%2C+B%22">Han, B</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+K%22">Li, K</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chu%2C+T%22">Chu, T</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bi%2C+M%22">Bi, M</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+H%22">Zhang, H</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yu%2C+Y%22">Yu, Y</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shi%2C+J%22">Shi, J</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+X%22">Zhang, X</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Z%22">Chen, Z</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Han%2C+C%22">Han, C</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bai%2C+T%22">Bai, T</searchLink><relatesTo>9</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=136076544
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/annonc/mdz063.070
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: N.PAG
    Titles:
      – TitleFull: 172P A multi-center, randomized, double-blind, parallel, two-group phase III clinical study on the efficacy and safety of QL1101 or bevacizumab in combination with paclitaxel and carboplatin in the first-line treatment of non-squamous non-small cell lung cancer
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Han, B
      – PersonEntity:
          Name:
            NameFull: Li, K
      – PersonEntity:
          Name:
            NameFull: Chu, T
      – PersonEntity:
          Name:
            NameFull: Bi, M
      – PersonEntity:
          Name:
            NameFull: Zhang, H
      – PersonEntity:
          Name:
            NameFull: Yu, Y
      – PersonEntity:
          Name:
            NameFull: Shi, J
      – PersonEntity:
          Name:
            NameFull: Zhang, X
      – PersonEntity:
          Name:
            NameFull: Chen, Z
      – PersonEntity:
          Name:
            NameFull: Han, C
      – PersonEntity:
          Name:
            NameFull: Bai, T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 04
              Text: 2019 Supplement
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 30
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1